Dimension Therapeutics Probability of Future Stock Price Finishing Under 5.97
Dimension Therapeutics' future price is the expected price of Dimension Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Dimension Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Please specify Dimension Therapeutics' target price for which you would like Dimension Therapeutics odds to be computed.
Dimension |
Dimension Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Dimension Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Dimension Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Dimension Therapeutics is not yet fully synchronised with the market data | |
| Dimension Therapeutics has some characteristics of a very speculative penny stock | |
| Dimension Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 14.88 M. Net Loss for the year was (53.19 M) with profit before overhead, payroll, taxes, and interest of 11.47 M. | |
| Dimension Therapeutics currently holds about 47.49 M in cash with (55.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.9. | |
| Roughly 71.0% of the company shares are held by institutions such as insurance companies |
Dimension Therapeutics Technical Analysis
Dimension Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Dimension Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Dimension Therapeutics. In general, you should focus on analyzing Dimension Stock price patterns and their correlations with different microeconomic environments and drivers.
Dimension Therapeutics Predictive Forecast Models
Dimension Therapeutics' time-series forecasting models is one of many Dimension Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Dimension Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Dimension Therapeutics
Checking the ongoing alerts about Dimension Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Dimension Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Dimension Therapeutics is not yet fully synchronised with the market data | |
| Dimension Therapeutics has some characteristics of a very speculative penny stock | |
| Dimension Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 14.88 M. Net Loss for the year was (53.19 M) with profit before overhead, payroll, taxes, and interest of 11.47 M. | |
| Dimension Therapeutics currently holds about 47.49 M in cash with (55.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.9. | |
| Roughly 71.0% of the company shares are held by institutions such as insurance companies |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Dimension Stock
If you are still planning to invest in Dimension Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dimension Therapeutics' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |